HUTCHMED ANNOUNCES REGULATORY FILINGS ACCEPTED FOR REVIEW FOR ORPATHYS® PLUS TAGRISSO® IN MET-DRIVEN EGFR-MUTATED LUNG CANCER IN EUROPE AND JAPAN

Reuters · 11/02 00:00

Please log in to view news